Smith & Nephew (SN) Competitors

Haleon (LON:HLN) and Smith & Nephew (LON:SN) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Is HLN or SN a better dividend stock?

Haleon pays an annual dividend of GBX 0.07 per share and has a dividend yield of 0.0%. Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.0%. Haleon pays out 39.5% of its earnings in the form of a dividend. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Does the media favor HLN or SN?

In the previous week, Haleon and Haleon both had 1 articles in the media. Smith & Nephew's average media sentiment score of 0.70 beat Haleon's score of 0.00 indicating that Smith & Nephew is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haleon	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Smith & Nephew	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend HLN or SN?

Haleon presently has a consensus target price of GBX 435, indicating a potential upside of 18.97%. Smith & Nephew has a consensus target price of GBX 1,379.33, indicating a potential downside of 2.59%. Given Haleon's higher possible upside, analysts plainly believe Haleon is more favorable than Smith & Nephew.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haleon	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Smith & Nephew	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Do institutionals and insiders believe in HLN or SN?

25.5% of Haleon shares are owned by institutional investors. Comparatively, 62.2% of Smith & Nephew shares are owned by institutional investors. 0.0% of Haleon shares are owned by insiders. Comparatively, 0.2% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Which has more risk and volatility, HLN or SN?

Haleon has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.

Is HLN or SN more profitable?

Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haleon	9.66%	6.54%	4.45%
Smith & Nephew	5.41%	5.85%	4.51%

Which has better earnings & valuation, HLN or SN?

Haleon has higher revenue and earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haleon	£11.02B	2.98	£1.07B	£0.17	2,189.40
Smith & Nephew	£7.08B	2.19	£382.79M	£27.77	50.98

Summary

Haleon and Smith & Nephew tied by winning 8 of the 16 factors compared between the two stocks.